| Erin Katie Idacavage, PT, MPT, GCS | |
|
1004 Progress Dr Ste 100, Lansing, KS 66043-6323 | |
| (913) 351-3838 | |
| (913) 351-3939 |
| Full Name | Erin Katie Idacavage |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1004 Progress Dr Ste 100, Lansing, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225134349 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2014005585 (Missouri) | Secondary |
| 225100000X | Physical Therapist | 11-03556 (Kansas) | Primary |
| Provider Name | Bluestem Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770219248 PECOS PAC ID: 4688041734 Enrollment ID: O20221103000298 |
News Archive
Dozens of suits against drug companies have been dismissed in federal and state courts because of a decision by the Supreme Court last year that makes it virtually impossible to sue generic manufacturers for failing to provide adequate warning of a prescription drug's dangers. This outrageous denial of a patient's right to recover fair damages makes it imperative that Congress or the Food and Drug Administration fashion a remedy.
Researchers in the U.S. say that an early start to school classes in the mornings means many teenagers lose much needed sleep and that makes them more likely to be moody and perform poorly in school.
One of the most challenging tasks of physicians has been differentiating between persistent COVID-19 and SARS-CoV-2 reinfection. Recently, a team of researchers analyzed SARS-CoV-2 sequences from the publicly available reports on reinfection and persistence. They further characterized the markers of reinfecting sequences and studied the mutation rate in newly evolved persistent variants.
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists and antagonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the presentation of positive clinical results from its randomized, placebo-controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Katie Idacavage, PT, MPT, GCS 6397 Lee Hwy Ste 300, Chattanooga, TN 37421-2564 Ph: (423) 238-7217 | Erin Katie Idacavage, PT, MPT, GCS 1004 Progress Dr Ste 100, Lansing, KS 66043-6323 Ph: (913) 351-3838 |
News Archive
Dozens of suits against drug companies have been dismissed in federal and state courts because of a decision by the Supreme Court last year that makes it virtually impossible to sue generic manufacturers for failing to provide adequate warning of a prescription drug's dangers. This outrageous denial of a patient's right to recover fair damages makes it imperative that Congress or the Food and Drug Administration fashion a remedy.
Researchers in the U.S. say that an early start to school classes in the mornings means many teenagers lose much needed sleep and that makes them more likely to be moody and perform poorly in school.
One of the most challenging tasks of physicians has been differentiating between persistent COVID-19 and SARS-CoV-2 reinfection. Recently, a team of researchers analyzed SARS-CoV-2 sequences from the publicly available reports on reinfection and persistence. They further characterized the markers of reinfecting sequences and studied the mutation rate in newly evolved persistent variants.
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists and antagonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the presentation of positive clinical results from its randomized, placebo-controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.
› Verified 7 days ago
Katherine Marie Martin, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 712 1st Ter, Ste 103, Lansing, KS 66043 Phone: 913-727-2022 Fax: 913-727-2033 | |
Mike A Mendiola, BS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1004 Progress Dr, Ste 100, Lansing, KS 66043 Phone: 913-351-3838 Fax: 913-351-3939 | |
Leif Erick Sanford, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 100 E Kansas St Ste C, Lansing, KS 66043 Phone: 913-758-0283 | |
Trisha M. Mcculloch, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 712 1st Ter, Ste 103, Lansing, KS 66043 Phone: 913-727-2022 Fax: 913-727-2033 | |
Linda A Stelter, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 210 N Plaza Dr, Lansing, KS 66043 Phone: 913-727-1284 | |
Jason S Langford, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1004 Progress Dr, Suite 100, Lansing, KS 66043 Phone: 913-351-3838 Fax: 913-351-3939 |